RussellAJ. Personal profile: Alan J. Russell. Rejuvenation Res, 2012; 15:108–112.
2.
ZhumadilovZ. Interview with Zhaxybay Zhumadilov. Rejuvenation Res, 2012; 15:339–342.
3.
KennedyB. Interview with Brian Kennedy. Rejuvenation Res, 2012; 15:534–537.
4.
ChurchGM. Personal profile: Interview with George Church. Rejuvenation Res, 2013; 16:171–172.
5.
ColesLS. Interview with L. Stephen Coles, MD, PhD. Rejuvenation Res, 2013; 16:250–253.
6.
SierraF. Interview with Felipe Sierra, PhD. Rejuvenation Res, 2013; 16:78–81.
7.
ApplebyJ. Interview with James Appleby. Rejuvenation Res, 2013; 16:432–434.
8.
BarkerRW. Personal profile: Interview with Richard Barker. Rejuvenation Res, 2013; 16:537–539.
9.
de GreyADNJ. The many-level value of proofs of concept. Rejuvenation Res, 2012; 15:121–122.
10.
de GreyADNJ. Biological versus medical limits on aging: A distinction we must not elide. Rejuvenation Res, 2012; 15:255–256.
11.
de GreyADNJ. What's really delaying the defeat of aging?. Rejuvenation Res, 2012; 15:347–348.
12.
de GreyADNJ. The future dominance of combination therapies: Implications for today's medical research. Rejuvenation Res, 2012; 15:443–444.
13.
de GreyADNJ. Dilemmas of discussing dramatic developments. Rejuvenation Res, 2012; 15:543–544.
14.
de GreyADNJ. Competing causes of chronic ill health: What do we do and what should we do?. Rejuvenation Res, 2013; 16:1–2.
15.
de GreyADNJ. The desperate need for a biomedically useful definition of “aging.”. Rejuvenation Res, 2013; 16:89–90.
16.
de GreyADNJ. Late-onset, preventative, combination treatments: The triple challenge facing the most promising anti-aging research paradigm. Rejuvenation Res, 2013; 16:177–178.
17.
de GreyADNJ. A divide-and-conquer assault on aging: Mainstream at last. Rejuvenation Res, 2013; 16(4):257–258.
18.
e GreyADNJ. Google's Calico: The war on aging has truly begun. Rejuvenation Res, 2013; 16:343–343.
19.
de GreyADNJ. Selling anti-aging research: The perils of mixed messages. Rejuvenation Res, 2013; 16:443–445.
20.
SørensenLM. Is it a sin to combat aging, or a sin not to?. Rejuvenation Res, 2012; 15:1–2.
21.
Kristjuhan Ü. Postponing aging and prolonging life expectancy with the knowledge-based economy. Rejuvenation Res, 2012; 15:132–133.
22.
ApplebyJ. The geroscience interest group (GSIG): Tracing pathological consequences of fundamental aging processes. Rejuvenation Res, 2013; 16:S13.
23.
CoeurnelleD. Collective consequences of a very long life. The right to life extension could/should be considered a human right. Rejuvenation Res, 2013; 1:S19.
24.
KhaltourinaD. Legal problems of registering substances and therapies to cure aging. Rejuvenation Res, 2013; 16:S27–S28.
KuhnR. International futures: Impact of decelerated or abolished aging on human demographic change. Rejuvenation Res, 2013; 16:S29–S30.
27.
PyszczynskiT, GreenbergJ. Understanding the paradox of opposition to long-term extension of the human lifespan: fear of death, cultural worldviews, and the illusion of objectivity. Rejuvenation Res, 2013; 16:S36–S37.
28.
UnderwoodM, HallW, BartlettH. What reassurances do the community need regarding life extension? Evidence from studies of community attitudes and an analysis of film portrayals. Rejuvenation Res, 2013; 16:S42.
29.
LitovchenkoM, ZhavoronkovA. New economic arguments for accelerating aging research. Rejuvenation Res, 2013; 16:S44.
30.
MicansP. Why orthodox medicine must change—the need for preventative/regenerative medicine. Rejuvenation Res, 2013; 16:S45.
